[go: up one dir, main page]

TR201002878A2 - Pharmaceutical compositions comprising cefpodoxime proxetil. - Google Patents

Pharmaceutical compositions comprising cefpodoxime proxetil.

Info

Publication number
TR201002878A2
TR201002878A2 TR2010/02878A TR201002878A TR201002878A2 TR 201002878 A2 TR201002878 A2 TR 201002878A2 TR 2010/02878 A TR2010/02878 A TR 2010/02878A TR 201002878 A TR201002878 A TR 201002878A TR 201002878 A2 TR201002878 A2 TR 201002878A2
Authority
TR
Turkey
Prior art keywords
pharmaceutical compositions
cefpodoxime proxetil
proxetil
cefpodoxime
relates
Prior art date
Application number
TR2010/02878A
Other languages
Turkish (tr)
Inventor
Bi̇lgi̇ç Mahmut
Original Assignee
Bi̇lgi̇ç Mahmut
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bi̇lgi̇ç Mahmut filed Critical Bi̇lgi̇ç Mahmut
Priority to TR2010/02878A priority Critical patent/TR201002878A2/en
Priority to PCT/TR2011/000092 priority patent/WO2011129792A1/en
Publication of TR201002878A2 publication Critical patent/TR201002878A2/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A61K31/542—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/545—Compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins, cefaclor, or cephalexine
    • A61K31/546—Compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins, cefaclor, or cephalexine containing further heterocyclic rings, e.g. cephalothin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
    • A61K9/0007—Effervescent
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches

Landscapes

  • Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Cephalosporin Compounds (AREA)
  • Medicinal Preparation (AREA)

Abstract

Mevcut buluş, sefpodoksim proksetil içeren farmasötik formülasyonlara ilişkindir.The present invention relates to pharmaceutical formulations comprising cefpodoxime proxetil.

TR2010/02878A 2010-04-13 2010-04-13 Pharmaceutical compositions comprising cefpodoxime proxetil. TR201002878A2 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
TR2010/02878A TR201002878A2 (en) 2010-04-13 2010-04-13 Pharmaceutical compositions comprising cefpodoxime proxetil.
PCT/TR2011/000092 WO2011129792A1 (en) 2010-04-13 2011-04-13 Water dispersible formulations comprising cefpodoxime proxetil

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
TR2010/02878A TR201002878A2 (en) 2010-04-13 2010-04-13 Pharmaceutical compositions comprising cefpodoxime proxetil.

Publications (1)

Publication Number Publication Date
TR201002878A2 true TR201002878A2 (en) 2011-10-21

Family

ID=44279055

Family Applications (1)

Application Number Title Priority Date Filing Date
TR2010/02878A TR201002878A2 (en) 2010-04-13 2010-04-13 Pharmaceutical compositions comprising cefpodoxime proxetil.

Country Status (2)

Country Link
TR (1) TR201002878A2 (en)
WO (1) WO2011129792A1 (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TR201007107A1 (en) * 2010-08-25 2012-03-21 B�Lg�� Mahmut Formulations of cefpodoxime proxetil containing taste regulating agent.
TR201007106A1 (en) * 2010-08-25 2012-03-21 Bi̇lgi̇ç Mahmut Cefpodoxime proxetil formulations.
TR201009168A2 (en) * 2010-11-05 2012-05-21 Bi̇lgi̇ç Mahmut Water dispersible cefpodoxime proxetil formulations.
CN103142506B (en) * 2013-04-03 2015-02-25 天津医药集团津康制药有限公司 Cefpodoxime proxetil granules and preparation method thereof

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4486425A (en) 1980-09-30 1984-12-04 Sankyo Company Limited 7-[2-(2-Aminothiazol-4-yl)-2-(syn)-methoxyiminoacetamido]-3-methoxymethyl-3-cephem-4-carboxylates
OA12687A (en) 2001-02-27 2006-06-21 Ranbaxy Lab Ltd Oral pharmaceutical composition of cefpodoxime proxetil.
JP4526247B2 (en) * 2002-07-08 2010-08-18 第一三共株式会社 Oral cephalosporins
MXPA05000641A (en) * 2002-07-16 2005-04-19 Ranbaxy Lab Ltd Dispersible tablets for oral administration.
WO2008057058A1 (en) * 2006-11-10 2008-05-15 Nobel Ilac Sanayii Ve Ticaret As Oral pharmaceutical compositions

Also Published As

Publication number Publication date
WO2011129792A1 (en) 2011-10-20

Similar Documents

Publication Publication Date Title
JOP20180102A1 (en) Pharmaceutical composition
UA107791C2 (en) Pesticidal compositions
EA201590534A1 (en) NEW BICYCLIC DERIVATIVES
IN2014DN09346A (en)
EA201690312A1 (en) IMPROVED LIPID COMPOSITION
PH12013500360B1 (en) Pesticidal compositions
EA201590887A1 (en) COMPOSITION
EA201200617A1 (en) POLYMERS ON THE BASIS OF CYCLODEXTRINE FOR DELIVERY OF MEDICINES
CL2014000815A1 (en) Compounds derived from insecticidal 2-methoxybenzamides; insecticidal compositions
CO6761388A2 (en) Pharmaceutical compositions comprising alisporivir
TR201002878A2 (en) Pharmaceutical compositions comprising cefpodoxime proxetil.
TR201007106A1 (en) Cefpodoxime proxetil formulations.
TR201009168A2 (en) Water dispersible cefpodoxime proxetil formulations.
BR112013000941A2 (en) 14-epi-analog formulations of vitamin d
TR201109160A2 (en) New pharmaceutical compositions containing eplerenone.
IT1406067B1 (en) EUDERMIC COMPOSITIONS.
BR112013016029A2 (en) phosphomycin pharmaceutical composition.
WO2012004073A3 (en) Use of beta-isophorone as solvent
TR201007107A1 (en) Formulations of cefpodoxime proxetil containing taste regulating agent.
UA42812U (en) Use of thiotriazolin ointment as an agent, having photoprotective properties
TN2013000218A1 (en) Pharmaceutical compositions comprising alisporivir